prof. dr. E. (Eelko) Hak

Full professor of Pharmacoepidemiology / Chair unit PharmacoTherapy, -Epidemiology, -Economics

Faculty of Science and Engineering

Telephone:

+31 6 5001 9923 (Secretariat)

+31 50 36 32772 (fax)

E-mail:

e.hak rug.nl

Homepage ORCID Research Portal

Publications

Novel observational study designs with new influenza vaccines

Hak, E., Mar-2015, In: Lancet Infectious Diseases. 15, 3, p. 253-254 2 p.

Research output: Contribution to journal › Article › Academic › peer-review

Birth cohort appeared to confound effect estimates of guideline changes on statin utilization

Bijlsma, M. J., Janssen, F., Lub, R., Bos, J. H. J., De Vries, F. M., Vansteelandt, S. & Hak, E., Mar-2015, In: Journal of Clinical Epidemiology. 68, 3, p. 334-340 7 p.

Research output: Contribution to journal › Article › Academic › peer-review

Is combined use of SSRIs and NSAIDs associated with an increased risk of starting peptic ulcer treatment?

Pouwels, K. B., Kalkman, G. A., Schagen, D., Visser, S. T. & Hak, E., Jul-2014, In: British Journal of Clinical Pharmacology. 78, 1, p. 192-193 2 p.

Research output: Contribution to journal › Letter › Academic › peer-review

Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies

Darvishian, M., Bijlsma, M. J., Hak, E. & van den Heuvel, E. R., Dec-2014, In: Lancet Infectious Diseases. 14, 12, p. 1228-1239 12 p.

Research output: Contribution to journal › Article › Academic › peer-review

Antibiotic use among dutch pregnant woman and the development of toddler asthma: The influence of confounding

Mulder, B., Pouwels, K. B., Schuiling-Veninga, N. C. M., Bos, J., De Vries, T. W., Jick, S. S. & Hak, E., Oct-2014, In: Pharmacoepidemiology and Drug Safety. 23, S1, p. 20-21 2 p.

Research output: Contribution to journal › Meeting Abstract › Academic

After adjusting for bias in meta-analysis seasonal influenza vaccine remains effective in community-dwelling elderly

Darvishian, M., Gefenaite, G., Turner, R. M., Pechlivanoglou, P., Van der Hoek, W., Van den Heuvel, E. R. & Hak, E., Jul-2014, In: Journal of Clinical Epidemiology. 67, 7, p. 734-744 11 p.

Research output: Contribution to journal › Review article › peer-review

A matched case-control study on polypharmacy and co-medications one year before drug treatment for Alzheimer's disease

Alghamdi, A., Vos ,de, S., Bos, J., Schuiling-Veninga, C., van Munster, B. C., Mubarik, S., Luijendijk, H. J. & Hak, E., Feb-2025, In: Journal of Alzheimer's disease : JAD. 103, 3, p. 706-713 8 p.

Research output: Contribution to journal › Article › Academic › peer-review

A pharmacological view on accounting for pharmacokinetic factors in the estimation of pharmaceutical emissions based on drug usage data: Comment on: Zillien C et al., Assessing city-wide pharmaceutical emissions to wastewater via modelling and passive sampling, Envir Int. vol. 185, March 2024, 108524

Klont, F., Bellinga, J. S., Giunchi, V., Balafas, S. & Hak, E., Feb-2025, In: Environment international. 196, 3 p., 109312.

Research output: Contribution to journal › Letter › Academic › peer-review

Correction to: Comparison of antipsychotic drug use in children and adolescents in the Netherlands before and during the COVID-19 pandemic

Gangapersad, R. N., Zhou, G., Garcia-Gomez, P., Bos, J., Hak, E., Koch, B. C. P., Schuiling-Veninga, C. C. M. & Dierckx, B., Jan-2025, In: European Child & Adolescent Psychiatry. 34, 1, p. 375

Research output: Contribution to journal › Erratum

Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: A systematic review and meta-analysis of European studies published up to 22 January 2024

Zhou, G., Dael, N., Verweij, S., Balafas, S., Mubarik, S., Oude Rengerink, K., Pasmooij, A. M. G., van Baarle, D., Mol, P. G. M., de Bock, G. H. & Hak, E., 19-Feb-2025, In: European Respiratory Review. 34, 175, 17 p.

Research output: Contribution to journal › Review article › peer-review